Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of GSK2881078 in Healthy Subjects
NCT02567773Phase 1Completed
- Sponsor
- GSK
- Start
- Sep 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of GSK2881078 in cachexia (3 arms), sponsored by GSK. Primary endpoints: Blood pressure, Heart rate and 4 more. Started Sep 2015; status: completed.
02
Drugs
GSK2881078
03
Conditions
cachexia
Beyond the preview
Go deeper on NCT02567773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02567773.